Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Zeria Pharmaceutical Co. Ltd. has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to a distinct examiner, BECKHARDT, LYNDSEY MARIE, who is the busiest examiner for the company. The prosecution is located within 1 distinct art unit, reflecting a specific focus for the company's current patent activity.
In the Biotechnology & Pharmaceuticals sector, having only 1 pending office action means the company's immediate patent office interaction is limited to a point of contact. The involvement of BECKHARDT, LYNDSEY MARIE suggests that the prosecution strategy can be highly tailored to the specific feedback provided by the examiner. This streamlined profile minimizes the complexity often found in larger biotech portfolios. Practitioners should focus on the specific standards of the 1 distinct art unit and the individual tendencies of BECKHARDT, LYNDSEY MARIE to navigate the prosecution of this Biotechnology & Pharmaceuticals application successfully.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BECKHARDT, LYNDSEY MARIE | 1 | 27.8% | +48.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19027175 | ENTERIC COATED TABLET | BECKHARDT, LYNDSEY MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19027175 | ENTERIC COATED TABLET | BECKHARDT, LYNDSEY MARIE | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19027175 | ENTERIC COATED TABLET | BECKHARDT, LYNDSEY MARIE | 1613 | §103 | Final Rejection | — | Pending | Jan 17, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial